Correction: 2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling

Lokesh Dalasanur Nagaprashantha1, Jyotsana Singhal1,2, Hongzhi Li3

  • 1Department of Medical Oncology, Beckman Research Institute of City of Hope, Comprehensive Cancer Center and National Medical Center, Duarte, CA 91010, USA.

Oncotarget
|March 9, 2022
PubMed

Insights

This study corrects a previous article's DOI. The corrected DOI is 10.18632/oncotarget.24720, ensuring proper citation and access to research findings.

Area of Science:

  • Correction of scientific literature
  • Bibliographic accuracy in biomedical research

Context:

  • Ensuring the integrity of scientific record
  • Facilitating accurate citation and retrieval of published research

Purpose:

  • To provide the correct Digital Object Identifier (DOI) for a specific article
  • To rectify a bibliographic error and maintain scholarly communication standards

Summary:

  • The article DOI previously listed as 10.18632/oncotarget.24720 has been corrected.
  • The accurate DOI is now provided to ensure correct referencing.

Impact:

  • Improved accessibility to the corrected article
  • Enhanced reliability of scientific databases and citation indexes
  • Facilitation of accurate scholarly communication